These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22394457)

  • 21. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort.
    Schimmelmann BG; Huber CG; Lambert M; Cotton S; McGorry PD; Conus P
    J Psychiatr Res; 2008 Oct; 42(12):982-90. PubMed ID: 18199456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social cognitive markers of short-term clinical outcome in first-episode psychosis.
    Montreuil T; Bodnar M; Bertrand MC; Malla AK; Joober R; Lepage M
    Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):105-14. PubMed ID: 20643633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
    J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial.
    Smeerdijk M; Keet R; Dekker N; van Raaij B; Krikke M; Koeter M; de Haan L; Barrowclough C; Schippers G; Linszen D
    Psychol Med; 2012 Aug; 42(8):1627-36. PubMed ID: 22152121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis.
    Gleeson JF; Cotton SM; Alvarez-Jimenez M; Wade D; Crisp K; Newman B; Spiliotacopoulos D; McGorry PD
    J Clin Psychiatry; 2010 Apr; 71(4):475-83. PubMed ID: 20021994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognition and recovery in first episode psychosis.
    Faber G; Smid HG; Van Gool AR; Wunderink L; Wiersma D; van den Bosch RJ
    Psychiatry Res; 2011 Jun; 188(1):1-6. PubMed ID: 21122926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of schizophrenia in patients with a first episode of psychosis.
    Ramirez N; Arranz B; Salavert J; Alvarez E; Corripio I; Dueñas RM; Perez V; San L
    Psychiatry Res; 2010 Jan; 175(1-2):11-4. PubMed ID: 19923008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
    Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
    Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of outcome three years after diagnosis of first episode psychosis.
    Lucas S; Redoblado-Hodge MA; Shores A; Brennan J; Harris A
    Psychiatry Res; 2008 Oct; 161(1):11-8. PubMed ID: 18786728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.
    Toftdahl NG; Nordentoft M; Hjorthøj C
    J Dual Diagn; 2016; 12(2):129-36. PubMed ID: 27070732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
    Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
    JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M; van der Sluis S; de Haan L
    Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reasons for cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Drug Alcohol Rev; 2004 Dec; 23(4):445-53. PubMed ID: 15763749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of recovery from psychosis Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years.
    Albert N; Bertelsen M; Thorup A; Petersen L; Jeppesen P; Le Quack P; Krarup G; Jørgensen P; Nordentoft M
    Schizophr Res; 2011 Feb; 125(2-3):257-66. PubMed ID: 21056926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between working alliance and clinical and functional outcome in a cohort of 400 patients with first-episode psychosis: a cross-sectional study.
    Melau M; Harder S; Jeppesen P; Hjorthøj C; Jepsen JR; Thorup A; Nordentoft M
    J Clin Psychiatry; 2015 Jan; 76(1):e83-90. PubMed ID: 25650684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.